TN2009000205A1 - Analogues de pyrazoles - Google Patents
Analogues de pyrazolesInfo
- Publication number
- TN2009000205A1 TN2009000205A1 TNP2009000205A TN2009000205A TN2009000205A1 TN 2009000205 A1 TN2009000205 A1 TN 2009000205A1 TN P2009000205 A TNP2009000205 A TN P2009000205A TN 2009000205 A TN2009000205 A TN 2009000205A TN 2009000205 A1 TN2009000205 A1 TN 2009000205A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- pyrazoles
- analogues
- preparation
- many
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention concerne les composés de formule (I), ou un de leurs sels et produits de solvatation pharmaceutiquement acceptables, formule dans laquelle R1 représente F ou H et des procédés pour la préparation de, des intermédiaires utilisés dans la préparation de, des compositions contenant, et les utilisations de, ces composés. Les composés conformes à la présente invention sont utiles dans de nombreuses maladies, de nombreux troubles et de nombreuses affections, en particulier des maladies, troubles et affections allergiques et respiratoires.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86733706P | 2006-11-27 | 2006-11-27 | |
PCT/IB2007/003518 WO2008065493A1 (fr) | 2006-11-27 | 2007-11-14 | Analogues du pyrazole |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2009000205A1 true TN2009000205A1 (fr) | 2010-10-18 |
Family
ID=39226772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2009000205A TN2009000205A1 (fr) | 2006-11-27 | 2009-05-22 | Analogues de pyrazoles |
Country Status (32)
Country | Link |
---|---|
US (1) | US7772269B2 (fr) |
EP (1) | EP2097407A1 (fr) |
JP (1) | JP4469924B2 (fr) |
KR (1) | KR20090074264A (fr) |
CN (1) | CN101541790A (fr) |
AP (1) | AP2009004849A0 (fr) |
AR (1) | AR063924A1 (fr) |
AU (1) | AU2007327004A1 (fr) |
BR (1) | BRPI0718672A2 (fr) |
CA (1) | CA2667566C (fr) |
CL (1) | CL2007003403A1 (fr) |
CO (1) | CO6180447A2 (fr) |
CR (1) | CR10745A (fr) |
CU (1) | CU23801B7 (fr) |
DO (1) | DOP2009000121A (fr) |
EA (1) | EA016588B1 (fr) |
EC (1) | ECSP099328A (fr) |
GE (1) | GEP20125386B (fr) |
GT (1) | GT200700104A (fr) |
HN (1) | HN2007000505A (fr) |
IL (1) | IL198412A0 (fr) |
MA (1) | MA30924B1 (fr) |
MX (1) | MX2009005526A (fr) |
NO (1) | NO20092413L (fr) |
NZ (1) | NZ576376A (fr) |
PE (1) | PE20081299A1 (fr) |
RS (1) | RS20090211A (fr) |
TN (1) | TN2009000205A1 (fr) |
TW (1) | TW200831495A (fr) |
UA (1) | UA92833C2 (fr) |
UY (1) | UY30743A1 (fr) |
WO (1) | WO2008065493A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100072090A (ko) | 2007-11-26 | 2010-06-29 | 화이자 인코포레이티드 | 5-lo 억제제로서의 피라졸 유도체 |
EP2151450A1 (fr) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Procédé de préparation d'oligopeptides cycliques microbiologiques |
EP2563359A1 (fr) * | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Nouveau traitement pour la dégénérescence maculaire liée à l'âge et la maladie ischémique oculaire associée à l'activation du complément par le ciblage de la 5-lipoxygénase |
TWI527809B (zh) * | 2011-01-24 | 2016-04-01 | 百靈佳殷格翰國際股份有限公司 | 作為crth2拮抗劑之吡唑化合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
CN1050840C (zh) | 1993-06-14 | 2000-03-29 | 美国辉瑞有限公司 | 咪唑脂氧合酶抑制剂 |
SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
JP3400392B2 (ja) * | 1994-10-18 | 2003-04-28 | ファイザー製薬株式会社 | 5−リポキシゲナーゼ阻害剤及び新規医薬組成物 |
US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
WO1997011079A1 (fr) | 1995-09-18 | 1997-03-27 | Pfizer Pharmaceuticals Inc. | Nouveaux inhibiteurs de l'imidazole lipoxygenase |
US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
JP2001100682A (ja) * | 1999-09-28 | 2001-04-13 | Sanyo Electric Co Ltd | サインシステム |
JP2001100686A (ja) * | 1999-09-28 | 2001-04-13 | Hitachi Kokusai Electric Inc | 表示データ取込方法及び比較検査装置 |
-
2007
- 2007-11-14 WO PCT/IB2007/003518 patent/WO2008065493A1/fr active Application Filing
- 2007-11-14 AU AU2007327004A patent/AU2007327004A1/en not_active Abandoned
- 2007-11-14 CA CA2667566A patent/CA2667566C/fr not_active Expired - Fee Related
- 2007-11-14 UA UAA200903927A patent/UA92833C2/ru unknown
- 2007-11-14 RS RSP-2009/0211A patent/RS20090211A/sr unknown
- 2007-11-14 EA EA200970422A patent/EA016588B1/ru not_active IP Right Cessation
- 2007-11-14 CN CNA2007800432018A patent/CN101541790A/zh active Pending
- 2007-11-14 MX MX2009005526A patent/MX2009005526A/es active IP Right Grant
- 2007-11-14 KR KR1020097010726A patent/KR20090074264A/ko not_active Application Discontinuation
- 2007-11-14 JP JP2009538801A patent/JP4469924B2/ja not_active Expired - Fee Related
- 2007-11-14 EP EP07848899A patent/EP2097407A1/fr not_active Withdrawn
- 2007-11-14 GE GEAP200711271A patent/GEP20125386B/en unknown
- 2007-11-14 AP AP2009004849A patent/AP2009004849A0/xx unknown
- 2007-11-14 BR BRPI0718672-0A patent/BRPI0718672A2/pt not_active IP Right Cessation
- 2007-11-14 NZ NZ576376A patent/NZ576376A/en not_active IP Right Cessation
- 2007-11-23 AR ARP070105216A patent/AR063924A1/es not_active Application Discontinuation
- 2007-11-26 GT GT200700104A patent/GT200700104A/es unknown
- 2007-11-26 US US11/944,732 patent/US7772269B2/en not_active Expired - Fee Related
- 2007-11-26 UY UY30743A patent/UY30743A1/es not_active Application Discontinuation
- 2007-11-26 PE PE2007001660A patent/PE20081299A1/es not_active Application Discontinuation
- 2007-11-26 TW TW096144833A patent/TW200831495A/zh unknown
- 2007-11-26 HN HN2007000505A patent/HN2007000505A/es unknown
- 2007-11-27 CL CL200703403A patent/CL2007003403A1/es unknown
-
2009
- 2009-04-23 CR CR10745A patent/CR10745A/es not_active Application Discontinuation
- 2009-04-27 IL IL198412A patent/IL198412A0/en unknown
- 2009-05-13 EC EC2009009328A patent/ECSP099328A/es unknown
- 2009-05-15 CU CU20090083A patent/CU23801B7/es not_active IP Right Cessation
- 2009-05-20 CO CO09051941A patent/CO6180447A2/es not_active Application Discontinuation
- 2009-05-22 TN TNP2009000205A patent/TN2009000205A1/fr unknown
- 2009-05-26 DO DO2009000121A patent/DOP2009000121A/es unknown
- 2009-05-27 MA MA31925A patent/MA30924B1/fr unknown
- 2009-06-24 NO NO20092413A patent/NO20092413L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30289B1 (fr) | Dérivés d'amines | |
TN2009000138A1 (fr) | Biaryl-ether-urees | |
MA28747B1 (fr) | Dérivés de pyridine | |
TN2009000112A1 (fr) | Derives de sulfonamides servant d'agonistes adrenergiques et d'antagonistes muscariniques | |
MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
TNSN07349A1 (fr) | Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur | |
MA29926B1 (fr) | Derives de pyrazine | |
MA27774A1 (fr) | Inhibiteurs de phosphatidylinositol 3-kinase | |
TN2011000316A1 (fr) | Derives de sulfonamides | |
MA31373B1 (fr) | Composes amino-heterocycliques | |
TNSN04151A1 (fr) | Derives de nicotinamide utiles comme inhibiteurs de pde4 | |
TN2009000450A1 (fr) | Derives de pyridine | |
TNSN05073A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
MA27990A1 (fr) | Derives de piperazine pour le traitement d'infections par le vih | |
MA30411B1 (fr) | Derives de triazolopyrazine utiles comme agent anticancereux | |
MA27801A1 (fr) | Nouveaux composes heterocycliques pour le traitement des affections inflammatoires et allergiques, leur procede de preparation et compositions pharmaceutiques les contenant | |
MA32466B1 (fr) | Derives de triazole utiles pour le traitement de maladies | |
TNSN07275A1 (fr) | Derives de triazole substitues, servant d'antagonistes d'ocytocine | |
MA27560A1 (fr) | Nouveaux derives de fluorglycoside heterocycliques, produits pharmaceutiques contenant ces composes et leur utilisation | |
MA31894B1 (fr) | Composes organiques | |
TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
MA30696B1 (fr) | Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique | |
MA28093A1 (fr) | Forme polymorphe de 3-phenylsulfonyl-8-piperazine-1-yl-quinoleine | |
WO2006055434A3 (fr) | Inhibiteurs de la beta-secretase formes d'amines tertiaires macrocycliques pour le traitement de la maladie d'alzheimer | |
TW200716547A (en) | Piperidin-4-yl-amide derivatives |